Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
about
Clinical relevance of brain volume measures in multiple sclerosis.Recent imaging advances in neurology.Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.The role of MRI in the evaluation of secondary progressive multiple sclerosis.Chemical exchange saturation transfer of the cervical spinal cord at 7 T.Outcome Measures in Clinical Trials for Multiple Sclerosis.Outcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.Spinal Cord as an Adjunct to Brain Magnetic Resonance Imaging in Defining "No Evidence of Disease Activity" in Multiple Sclerosis.The effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosisNovel composite MRI scale correlates highly with disability in multiple sclerosis patients.Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7TFully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MSThe Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis.Spinal cord gray matter atrophy correlates with multiple sclerosis disabilitySecondary Progressive Multiple Sclerosis: Definition and Measurement.Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.Axonal loss in the multiple sclerosis spinal cord revisited.The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.Imaging outcome measures for progressive multiple sclerosis trialsA white matter lesion-filling approach to improve brain tissue volume measurements.Putaminal alteration in multiple sclerosis patients with spinal cord lesions.MRI-Based Measurement of Brain Stem Cross-Sectional Area in Relapsing-Remitting Multiple Sclerosis.Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis.A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple Sclerosis.Spinal cord atrophy as a primary outcome measure in phase II trials of progressive multiple sclerosis.A longitudinal MRI study of cervical cord atrophy in multiple sclerosis.Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.
P2860
Q30738659-D0D1EEEB-4C68-46AA-8C73-C268556C4BF7Q30916063-0818047A-9532-4A85-98C4-438B6FA86C9AQ30958322-4662AFCF-01A2-4125-8786-2FDB5399BB5DQ31033345-AFF6CD86-573C-4EC7-8CEB-663C11C64F49Q31117628-021928D9-BD89-4884-B2CE-EF78FFBB6ED0Q31160866-FB1AEFCB-1CF3-46AF-A686-210CF5CDCC7CQ33634866-B5B90744-C63C-481F-B949-304002ABCA47Q33769234-CF0273A7-415D-4BAC-9CDA-0B161469534CQ36156669-84550EE2-7AB6-4E3D-B953-237E09D52936Q36307718-4BF25F4E-37F1-41F9-8E38-3913942E7113Q36495185-96A0F892-7659-45BC-BA4E-44EF4BFE489DQ36515844-6F7840FE-AF49-4774-BEEB-41BC48590F9FQ37596025-6D3C358F-9153-49F6-AA3E-614FFFF5FF2EQ37651386-8993A8CE-EACE-4E10-80C1-FDCA26305DCAQ38831720-9A31D6CD-7AF2-4C91-AAE0-EC7C849CE386Q38923464-67B9DE3E-9E22-4CFD-BFE2-094BCDA69941Q39125767-FC210C7D-D042-4F05-8A44-5FB1F9384562Q39125774-7F9492EA-380C-4A8B-9B5A-685E4FF9E8B2Q39352370-681362D5-F596-4287-A7B2-157216E05D4EQ41475478-2B494E66-B2BD-4067-BEB8-F49DF28D2AE1Q41686940-EACE6899-5778-4102-A05D-A918C4B3DB2EQ42660399-C37083B8-A9C7-4F3B-BB71-DCA26414C821Q42970123-58841164-B854-451A-83FD-D78E4A2D6D40Q48179442-F10F7C62-AA6E-4A17-BEB6-C44D21E9EB31Q48220840-6CBA13B4-C9AB-4603-A75A-41606372F3E3Q48222881-1DE9E782-3532-40B0-BC4F-9D88A3F1BA29Q48380147-F00A2DE6-B2E6-46FC-A289-9A8A1B6D1076Q48587582-67DA74BF-D740-49CB-8259-CB06FBC773EAQ50870839-07C11C8F-2D65-4CBB-A420-D0FF80128217Q50922131-B52EA815-EFFC-4094-A9F7-842CF9C876ACQ50945427-21F05DE6-7070-4DA6-97DC-807C79A4D92F
P2860
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Magnetic resonance imaging cor ...... osis of long disease duration.
@ast
Magnetic resonance imaging cor ...... osis of long disease duration.
@en
type
label
Magnetic resonance imaging cor ...... osis of long disease duration.
@ast
Magnetic resonance imaging cor ...... osis of long disease duration.
@en
prefLabel
Magnetic resonance imaging cor ...... osis of long disease duration.
@ast
Magnetic resonance imaging cor ...... osis of long disease duration.
@en
P2093
P2860
P50
P356
P1476
Magnetic resonance imaging cor ...... osis of long disease duration.
@en
P2093
C Gasperini
C H Polman
C Stippich
D H Miller
D R Altmann
J J G Geurts
P2860
P356
10.1177/1352458513492245
P577
2013-06-27T00:00:00Z